Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Akers Biosciences

(NASDAQ: AKER)
Add to Portfolio
+1.01 (+21.54%)
as of Apr 7, 2020


Date Form Description HTML Word PDF Excel
Apr 07, 2020 D Small Company Offering and Sale of Securities Without Registration  
Apr 07, 2020 8-K Current report filing
Apr 07, 2020 S-3/A Securities Registration Statement (simplified form)
Mar 25, 2020 10-K Annual Report
Mar 24, 2020 8-K Current report filing
Jan 31, 2020 8-K Current report filing
Jan 17, 2020 8-K Current report filing
Jan 09, 2020 SC 13G Statement of Ownership
Jan 06, 2020 8-K Current report filing
Dec 19, 2019 SC 13G Statement of Ownership
Dec 18, 2019 SC 13G Statement of Ownership
Dec 13, 2019 SC 13G Statement of Ownership
Dec 09, 2019 424B4 Prospectus filed pursuant to Rule 424(b)(4)
Dec 05, 2019 DEFA14A Additional Proxy Soliciting Materials (definitive)
Dec 05, 2019 S-1MEF Registration of Additional Securities (up to 20%)
Dec 04, 2019 S-1/A Securities Registration Statement
Dec 04, 2019 8-K Current report filing
Dec 04, 2019 PRER14A Proxy Soliciting Materials (revised)
Nov 29, 2019 S-1/A Securities Registration Statement
Nov 29, 2019 8-K Current report filing
Nov 25, 2019 PRE 14A Proxy Statement - Notice of Shareholders Meeting (preliminary)
Nov 14, 2019 10-Q Quarterly Report
Nov 12, 2019 DEF 14A Proxy Statement (definitive)
Nov 08, 2019 8-K Current report filing
Nov 01, 2019 8-K Current report filing